Pakistani Pharmaceuticals & Biotech Strong Balance Sheet Stocks

GlaxoSmithKline Pakistan

Market Cap: PK₨121.2b

Operates as a biopharma company in Pakistan.

Hoechst Pakistan

Market Cap: PK₨30.3b

Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.

Abbott Laboratories (Pakistan)

Market Cap: PK₨93.6b

Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.

Highnoon Laboratories

Market Cap: PK₨48.5b

Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.

Liven Pharmaceuticals

Market Cap: PK₨5.6b

Manufactures and markets pharmaceutical products in Pakistan.

AGP

Market Cap: PK₨51.3b

Manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan.

Citi Pharma

Market Cap: PK₨19.8b

Engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan.

Ferozsons Laboratories

Market Cap: PK₨13.6b

Engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Afghanistan, Sri Lanka, the Philippines, Kenya, Myanmar, Kyrgyzstan, Mongolia, Cambodia, and internationally.

Searle

Market Cap: PK₨45.5b

Manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally.

Otsuka Pakistan

Market Cap: PK₨4.5b

Manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan.

BF Biosciences

Market Cap: PK₨16.7b

A diversified biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products.